20 unknown, 15 completed, 8 recruiting, 2 terminated. 24 Not applicable, 5 Early Phase 1, 5 Phase 1, 2 Phase 2.
Follow Positron-emission Tomography: new trials by email Literature Review of Positron-emission Tomography trials Research Report on Positron-emission Tomography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica Inflammatory Rheumatism, 18-FDG | Unknown | University Hospital, Brest | 210 | 2024-09-01 | 2024-08-20 | |
| ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer standard-of-care imaging (18F-FDG PET/CT), 68Ga-MY6349 PET/CT - Tumor, Solid Tumor | Not applicable | Terminated | The First Affiliated Hospital of Xiamen University | 149 | 2024-06-13 | 2026-05-28 |
| 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease 68Ga-PSFA - PSMA, FAP | Early Phase 1 | Recruiting | First Affiliated Hospital of Chongqing Medical University | 30 | 2024-05-20 | 2025-06-04 |
| PET-CT Imaging Features of Meibomian Glands MGD-Meibomian Gland Dysfunction, Positron-Emission Tomography | Unknown | Zhongnan Hospital | 100 | 2024-01-31 | 2024-03-22 | |
| Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer [68Ga]Ga-NOTA-WWH347 or [18F]F-H3RESCA-WWH347 - Positron-Emission Tomography, Colorectal Neoplasms | Not applicable | Unknown | Huashan Hospital | 40 | 2023-12-01 | 2024-02-20 |
| Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors [68Ga]Ga-NOTA-T4 or [18F]AlF-RESCA-T4 - Positron-Emission Tomography, Neoplasms | Not applicable | Unknown | Huashan Hospital | 60 | 2023-12-01 | 2024-06-18 |
| ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT - Tumor, Solid Tumor | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 90 | 2023-10-01 | 2024-12-18 |
| The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus MRI scan including arterial spin labelling of the brain, CT perfusion scan of the brain, FDG-PET scan of the brain - Status Epilepticus, Ictal-interictal Continuum | Not applicable | Recruiting | Universitaire Ziekenhuizen KU Leuven | 200 | 2023-10-01 | 2024-12-27 |
| 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT - SSTR2, FAP | Not applicable | Recruiting | The First Affiliated Hospital of Xiamen University | 30 | 2023-04-09 | 2025-08-08 |
| Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases Positron-Emission Tomography, Alpha Synuclein Pathology | Unknown | Huashan Hospital | 20 | 2023-03-17 | 2023-03-14 | |
| Gene Expression Profiles in Spinal Tuberculosis. Tuberculosis, Spinal, Tuberculosis, Osteoarticular | Recruiting | University of Cape Town | 100 | 2022-10-25 | 2024-08-23 | |
| 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT - Tumor, Solid, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 27 | 2022-07-01 | 2023-02-27 |
| Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma Positron-Emission Tomography | Unknown | Peking University Cancer Hospital & Institute | 40 | 2022-06-01 | 2022-06-09 | |
| 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies 68Ga-FAP-CHX - Tumor, Positron-Emission Tomography | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Fujian Medical University | 50 | 2022-05-01 | 2023-09-21 |
| FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application 68Ga-Fibroblast activation protein inhibitor - Malignant Tumors, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Anhui Medical University | 22 | 2022-04-28 | 2025-08-13 |
| Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer 18F-FDG - Tumor, Solid, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 67 | 2022-03-01 | 2023-02-27 |
| Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer stereotactic body radiotherapy, androgen deprivation therapy, Radiotherapy - Prostate Cancer Metastatic, Radiation Therapy | Not applicable | Recruiting | Karin Soderkvist | 118 | 2021-10-27 | 2026-02-17 |
| 68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases 68Ga-NOTA Evans Blue - Positron-Emission Tomography | Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 80 | 2021-04-25 | 2023-09-21 |
| 68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease 68Ga-FAPI-04 - Fibrosis, Positron-Emission Tomography | Early Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 500 | 2021-04-01 | 2023-09-21 |
| 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer 68Ga-PSMA-11 - Prostate Cancer, Positron-Emission Tomography | Early Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 600 | 2020-10-10 | 2023-09-21 |
Showing 20 of 47. Sign in to see all of them.
Neoplasms (12) · Disease (6) · Lymphoma (3) · Neoplasm Metastasis (3) · Carcinoma, Non-Small-Cell Lung (2) · Cardiotoxicity (2) · Colorectal Neoplasms (2) · Melanoma (2) · Neuroinflammatory Diseases (2) · Prostatic Neoplasms (2) · Thyroid Neoplasms (2) · Alzheimer Disease (1) · Bone Diseases, Infectious (1) · Brain Neoplasms (1) · Breast Neoplasms (1)
Pathological Conditions, Signs and Symptoms (16) · Pathologic Processes (15) · Neoplasms (13) · Neoplasms by Site (13) · Neoplasms by Histologic Type (6) · Nervous System Diseases (6) · Immune System Diseases (5) · Hemic and Lymphatic Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplastic Processes (4) · Skin and Connective Tissue Diseases (4) · Brain Diseases (3) · Central Nervous System Diseases (3)
Positron Emission Tomography Computed Tomography (3) · 68Ga-FAPI (2) · Androgen Antagonists (1) · Biopsy (1) · Biopsy, Needle (1) · Cerebrovascular Circulation (1) · Fluorodeoxyglucose F18 (1) · Gonadotropin-Releasing Hormone (1) · Immunization (1) · Magnetic Resonance Spectroscopy (1) · Multiparametric Magnetic Resonance Imaging (1) · Positron-Emission Tomography (1) · Radiosurgery (1) · Radiotherapy (1) · Radiotherapy, Image-Guided (1)
First Affiliated Hospital of Fujian Medical University (7) · The First Affiliated Hospital of Xiamen University (6) · Peking University Cancer Hospital & Institute (5) · Fifth Affiliated Hospital, Sun Yat-Sen University (3) · Huashan Hospital (3) · Bayer (2) · ImaginAb, Inc. (2) · University Hospital, Brest (2) · Aarhus University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · Copenhagen University Hospital, Rigshospitalet (1) · First Affiliated Hospital of Chongqing Medical University (1) · Imperial College London (1) · Istituto Clinico Humanitas (1) · Karin Soderkvist (1)
China (26) · Denmark (3) · France (3) · Sweden (3) · United States (3) · Canada (2) · Australia (1) · Belgium (1) · Italy (1) · Netherlands (1) · South Africa (1) · United Kingdom (1)
Fang Xie, PhD (3) · Long Sun, PhD (3) · Zhi Yang, PhD (3) · David Groheux, MD-PhD (1) · David JM Lewis, MD (1) · Egesta Lopci (1) · Huiqin Xu (1) · Jean Louis Bonnal, MD (1) · Lena Palaniyappan, MBBS/PhD (1) · Liangdi Xie, MD (1) · Lisbeth Marner, MD PhD DMSc (1) · Lorenzo Nardo, MD (1) · Matthieu Resche-Rigon, MD-PHD (1)
PMID 10749239, PMID 12183436, PMID 12542520, PMID 14602860, PMID 15767544, PMID 16549957, PMID 17363526, PMID 17575208, PMID 18570153, PMID 19721715, PMID 19817894, PMID 19872213, PMID 22236832, PMID 22371645, PMID 22614695, PMID 23618062, PMID 25143865, PMID 29496096, PMID 29626119, PMID 30072500, PMID 30850501, PMID 31631858, PMID 31912902, PMID 31974680, PMID 32222810, PMID 32632460, PMID 33179149, PMID 33778675, PMID 34413145, PMID 34424505, PMID 34581274, PMID 35551610, PMID 36723892, PMID 36994205, PMID 37385675, PMID 37601238, PMID 38176714, PMID 38918806, PMID 39509246, PMID 39520516, PMID 41882599, PMID 42180616, PMID 9065413
2008 (1)